• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON, S.A. BD PLASTIPAK¿ CONCENTRIC LUER LOCK SYRINGE; HYPODERMIC SYRINGE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON, S.A. BD PLASTIPAK¿ CONCENTRIC LUER LOCK SYRINGE; HYPODERMIC SYRINGE Back to Search Results
Catalog Number 300865
Device Problem Device Operates Differently Than Expected (2913)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 01/31/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(6).A sample is available for evaluation.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that the plunger on a bd plastipak¿ concentric luer lock syringe is difficult to move and takes ¿more force¿ to draw and deliver medications.There was no report of medical interventions.
 
Manufacturer Narrative
Investigation summary: it has been received 2 unused samples of 50ll lot 1711263 ref.300865 and 1 sealed sample of 50ll lot 7266840 ref.309653.This second reference is not evaluated since it is not manufactured at bd (b)(4) plant.Dhr of lot 1711263 has been reviewed not finding any annotation or deviation regarding the alleged defect.On checking the results of silicone weight, break out and sustaining force tests performed during manufacturing process of lot 1711263, they are within specification limits.Silicone weight, break out and sustaining force tests are done with the two samples received according to procedures.Results meet specification limits.No defect can be found in the blisters of both samples.Final products in this manufacturing line, for this reference and lot size are sampled and they are subjected to visual and functional inspections during the different manufacturing sub-processes according to procedures.According to results obtained from tests performed with samples received and the results during manufacturing process, no manufacturing defect has been found in the samples received related to difficult to move the plunger or related to packaging.Defect: plunger difficult to move.It has been received 2 unused samples of 50ll lot 1711263 ref.300865 and 1 sealed sample of 50ll lot 7266840 ref.309653.This second reference is not evaluated since it is not manufactured at bd (b)(4) plant.Dhr of lot 1711263 has been reviewed not finding any annotation or deviation regarding the alleged defect.On checking the results of silicone weight, break out and sustaining force tests performed during manufacturing process of lot 1711263, they are within specification limits (jg-500 for 50ml syringes break out force max.9 lbs, sustaining force max.5lbs; silicone weight ref: 6mg, max: 25mg ).Silicone weight, break out and sustaining force tests are done with the two samples received according to procedures (b)(4).Results meet specification limits.No defect can be found in the blisters of both samples.Final products in this manufacturing line, for this reference and lot size are sampled and they are subjected to visual and functional inspections during the different manufacturing sub-processes according to procedures (jg-301, jg-302, jg-303 and jg-304): visual inspection.Molding: 2 injections per shift.Printing: 32 samples per two hours, after any intervention in the equipment and once at the beginning of the shift.Assembly: 32 samples per two hours, after any intervention in the equipment and once at the beginning of the shift.Primary packaging: 1 advance-step (without product) per hour, after any intervention in the equipment, and once at the beginning of the shift.Secondary packaging: 1 shelf-package per pallet.Functional inspection.Printing: once in the first pallet, and once in last pallet of the lot.Assembly: once in the first pallet and once in last pallet of the lot.Primary packaging: once in the first pallet and once in last pallet of the lot.According to results obtained from tests performed with samples received and the results during manufacturing process, no manufacturing defect has been found in the samples received related to difficult to move the plunger or related to packaging.Investigation conclusion: according to results obtained from tests performed with samples received and the results during manufacturing process, no manufacturing defect has been found in the samples received related to difficult to move the plunger or related to packaging.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD PLASTIPAK¿ CONCENTRIC LUER LOCK SYRINGE
Type of Device
HYPODERMIC SYRINGE
Manufacturer (Section D)
BECTON DICKINSON, S.A.
camino de valdeolivia
s/n
san agustin de guadalix
MDR Report Key7325923
MDR Text Key102081638
Report Number3003152976-2018-00069
Device Sequence Number1
Product Code FMF
Combination Product (y/n)N
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,o
Type of Report Initial,Followup
Report Date 03/15/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Pharmacist
Device Expiration Date10/31/2022
Device Catalogue Number300865
Device Lot Number1711263
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/07/2018
Initial Date Manufacturer Received 02/14/2018
Initial Date FDA Received03/08/2018
Supplement Dates Manufacturer Received02/14/2018
Supplement Dates FDA Received03/15/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-